• Nano-Code: 2020-1-BG01-KA226-HE-095017
Partnership Area
What are you looking for?

he-lp5

HE Undergraduates in nanotechnology (EQF 7):

HE-LP5Nanomaterials and nanotechnology for innovative anti-COVID-19 solutions
SummaryThis training unit provides information about nanomaterials as excellent candidates against CoVs infections because of their particular features that allow instant, precise, and quick detection of contagious agents and their accurate and rapid treatment. The advances of nanotechnology in offering precise, sensitive, and fast diagnostic tools to detect infection at an early stage of its development are described. Information is presented concerning the novel nanotechnology-based biosensors, diagnostic devices, antiviral drugs, and vaccines that have been developed or repurposed to combat the modern pandemic. Emphasis is given to the advances in nanotechnology for the inactivation of viruses and control of the COVID-19 epidemic. The emergency of nanoethics as a new bioethical subdiscipline and the nanoethics aspects of mRNA vaccines as genetic engineering products are discussed. Some fields of application of nanomedicine in the surrounding of mRNA technology are commented in light of COVID-19.
ULOs
Knowledge & Skills		Upon completion of HE-LP5 the trainee will be able to:
  • Describe the current methods of detection of SARS-CoV-2;
  • Define the properties and categories of nanomaterials for SARS-CoV-2 detection;
  • Understand the differences between nanomaterials;
  • Demonstrate the main challenges and limitations of nanomaterials;
  • Discuss the application of nanomaterials for SARS-CoV-2 detection.
  • List the current laboratory methods for diagnosis of SARS-CoV-2;
  • Understand the categories of nanotechnology (nano biosensors, point-of-care testing and nanopore target sequencing);
  • Identify the differences between nano biosensors;
  • Illustrate the main challenges and limitations of nanotechnology in COVID-19;
  • Discuss the application of nanotechnology for diagnosis of SARS-CoV-2.
  • Emphasize the SARS-CoV-2 and COVID-19 effects on thinking in research and clinical medicine;
  • Know the current developments of versatile nano-scale carrier platforms;
  • Explain the principles of construction and operation of the nano-based delivery systems for antiviral drugs;
  • Make an overview of the nanoformulations developed for the delivery of antiviral drugs;
  • Present the use of viral capsids for drug delivery.
  • describe the most important tasks of ethical reflection with regard to the application of new technologies using the example of nanotechnology in the field of the development of molecular genetically based vaccines (functions of "nanoethics");
  • understand the basic concerns of technology-related bioethics in the sense of a technology assessment encompassing all social, health and political aspects (risks and chances);
  • distinguish and weight the different issues of bioethics in the field of nanobiotechnology, so that the special problems of "nanoethics" in the medical field become clear;
  • exemplify and discuss the different ethical problems that arise in connection with the development of mRNA vaccines;
CompositionLO 3.1. Nanomaterials in design and application of SARS-CoV-2 detection methods
LO 3.2. Nanotechnology in diagnostic techniques for SARS-CoV-2
LO 4.2. New platforms to control viral infections: nano-scale carriers and drug delivery systems
LO 6.1. Integration of social and ethical studies into nanotechnology developments
(Self)AssessmentHE-LP5 Test
Credit points6
ValidationCertificate
This project has been funded with support from the European Commission. This web-site reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein.